BIONOMICS LIMITED

Highlights Bionomics Limited

Equities

BNOX

US09063M2052

Market Closed - Nasdaq Other stock markets 16:30:00 2024-06-28 EDT			5-day change	1st Jan Change
0.767 ^USD	+3.51%		-0.47%	-48.18%

05-31	Bionomics Limited announced that it expects to receive $70 million in funding	CI
03-21	Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder	03-21	CI
Bionomics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	03-15	CI
Bionomics Limited Announces Successful and Favorable Outcomes of an End-Of-Phase 2 Meeting Meeting with the U.S. Food and Drug Administration	23-10-16	CI
Bionomics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-29	CI
Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder	23-09-28	CI
Bionomics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer